TNSN98124A1 - SOLUBILIZED SERTRALINE COMPOSITIONS - Google Patents

SOLUBILIZED SERTRALINE COMPOSITIONS

Info

Publication number
TNSN98124A1
TNSN98124A1 TNTNSN98124A TNSN98124A TNSN98124A1 TN SN98124 A1 TNSN98124 A1 TN SN98124A1 TN TNSN98124 A TNTNSN98124 A TN TNSN98124A TN SN98124 A TNSN98124 A TN SN98124A TN SN98124 A1 TNSN98124 A1 TN SN98124A1
Authority
TN
Tunisia
Prior art keywords
sertraline
compositions
solubilized
solubilized sertraline
sertraline compositions
Prior art date
Application number
TNTNSN98124A
Other languages
French (fr)
Inventor
Thomas Friesen Dwayne
Max Herbig Scott
Mysore Shanker Ravi
Blair West James
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971159&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TNSN98124(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of TNSN98124A1 publication Critical patent/TNSN98124A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Abstract

L'INVENTION CONCERNE UNE COMPOSITION COMPRENANT DE DE LA SERTRALINE ET UN AGENT SOLUBILISANT, PERMETTANT D'ATTEINDRE UNE PLUS FORTE CONCENTRATION DE SERTRALINE DISSOUTE DANS UN ENVIRONNEMENT D'UTILISATION. ELLE CONCERNE EGALEMENT UN PROCEDE POUR ACCROITRE LA SOLUBILITE DE LA SERTRALINE ET UN PROCEDE DE PREPARATION D'UNE FORME POSOLOGIQUE DE SERTRALINE A SOLUBILITE ACCRUE. APPLICATION : UTILISATION POUR LE TRAITEMENT D'UNE MALADIE PSYCHIATRIQUE OU D'AUTRES MALADIESTHE INVENTION RELATES TO A COMPOSITION COMPRISING SERTRALINE AND A SOLUBILIZING AGENT FOR ACHIEVING HIGHER CONCENTRATION OF DISSOLVED SERTRALINE IN A USING ENVIRONMENT. IT ALSO CONCERNS A PROCESS FOR INCREASING THE SOLUBILITY OF SERTRALINE AND A PROCESS FOR PREPARING A DOSAGE FORM OF SERTRALINE WITH INCREASED SOLUBILITY. APPLICATION: USE FOR THE TREATMENT OF PSYCHIATRIC DISEASE OR OTHER DISEASES

TNTNSN98124A 1997-07-01 1998-06-30 SOLUBILIZED SERTRALINE COMPOSITIONS TNSN98124A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5141397P 1997-07-01 1997-07-01

Publications (1)

Publication Number Publication Date
TNSN98124A1 true TNSN98124A1 (en) 2005-03-15

Family

ID=21971159

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN98124A TNSN98124A1 (en) 1997-07-01 1998-06-30 SOLUBILIZED SERTRALINE COMPOSITIONS

Country Status (34)

Country Link
EP (1) EP0999829A1 (en)
JP (1) JP2000514100A (en)
KR (1) KR100366373B1 (en)
CN (1) CN1261794A (en)
AP (1) AP1192A (en)
AR (3) AR015917A1 (en)
AU (1) AU742535B2 (en)
BG (1) BG103918A (en)
BR (1) BR9810739A (en)
CA (1) CA2290974C (en)
CO (1) CO4940495A1 (en)
DZ (1) DZ2548A1 (en)
EA (1) EA002481B1 (en)
HN (1) HN1998000102A (en)
HR (1) HRP980377A2 (en)
HU (1) HUP0002236A3 (en)
ID (1) ID23429A (en)
IL (1) IL133076A (en)
IS (1) IS5260A (en)
MA (1) MA24587A1 (en)
NO (1) NO996520L (en)
OA (1) OA11243A (en)
PA (1) PA8454301A1 (en)
PE (1) PE97199A1 (en)
PL (1) PL337804A1 (en)
SK (1) SK181099A3 (en)
TN (1) TNSN98124A1 (en)
TR (1) TR199903297T2 (en)
TW (1) TW550087B (en)
UA (1) UA67741C2 (en)
UY (1) UY25071A1 (en)
WO (1) WO1999001120A1 (en)
YU (1) YU68299A (en)
ZA (1) ZA985708B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EE200200357A (en) 1999-12-23 2003-10-15 Pfizer Products Inc. Pharmaceutical compositions providing increased concentrations of the drug substance
US20030086972A1 (en) * 2000-08-09 2003-05-08 Appel Leah E. Hydrogel-driven drug dosage form
JP2004507502A (en) 2000-08-30 2004-03-11 ファイザー・プロダクツ・インク Sustained release formulation for growth hormone secretagogue
US20040191207A1 (en) * 2003-03-31 2004-09-30 Lipari John M. Alpha-hydroxy acid ester drug delivery compositions and methods of use
US20100105638A1 (en) * 2007-03-12 2010-04-29 Kerstin Den-Braven Cosmetic compositions
EP2520300A4 (en) * 2009-12-29 2013-05-08 Kowa Co Pharmaceutical composition for oral administration
WO2011081117A1 (en) * 2009-12-29 2011-07-07 興和株式会社 Solid pharmaceutical composition for oral administration
CN109908354A (en) * 2017-12-12 2019-06-21 万特制药(海南)有限公司 Sertraline hydrochloride takes orally concentrate and its preparation process

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4803076A (en) * 1986-09-04 1989-02-07 Pfizer Inc. Controlled release device for an active substance
ATE96999T1 (en) * 1989-08-30 1993-11-15 Pfizer USE OF SERTRALINE TO TREAT CHEMICAL ADDICTION.
ZA97976B (en) * 1996-04-05 1997-08-18 Alza Corp Uniform drug delivery theraphy.

Also Published As

Publication number Publication date
BG103918A (en) 2000-07-31
SK181099A3 (en) 2000-07-11
KR20010013365A (en) 2001-02-26
AP1192A (en) 2003-07-23
PL337804A1 (en) 2000-09-11
UA67741C2 (en) 2004-07-15
AR015917A1 (en) 2001-05-30
HUP0002236A2 (en) 2003-08-28
CA2290974C (en) 2004-04-27
IL133076A (en) 2003-12-10
ZA985708B (en) 2000-01-10
YU68299A (en) 2002-06-19
NO996520L (en) 2000-02-29
EA199900962A1 (en) 2000-08-28
KR100366373B1 (en) 2003-01-14
PE97199A1 (en) 1999-10-05
IL133076A0 (en) 2001-03-19
CA2290974A1 (en) 1999-01-14
UY25071A1 (en) 2000-12-29
AR040279A2 (en) 2005-03-23
AR040280A2 (en) 2005-03-23
DZ2548A1 (en) 2003-02-08
IS5260A (en) 1999-11-19
WO1999001120A1 (en) 1999-01-14
EP0999829A1 (en) 2000-05-17
NO996520D0 (en) 1999-12-28
BR9810739A (en) 2000-09-12
HN1998000102A (en) 1999-01-08
TR199903297T2 (en) 2000-07-21
EA002481B1 (en) 2002-06-27
CN1261794A (en) 2000-08-02
PA8454301A1 (en) 2000-09-29
TW550087B (en) 2003-09-01
JP2000514100A (en) 2000-10-24
AU7544898A (en) 1999-01-25
AP9801280A0 (en) 1998-06-30
MA24587A1 (en) 1998-12-31
ID23429A (en) 2000-04-20
CO4940495A1 (en) 2000-07-24
HUP0002236A3 (en) 2003-12-29
HRP980377A2 (en) 1999-04-30
AU742535B2 (en) 2002-01-03
OA11243A (en) 2003-07-24

Similar Documents

Publication Publication Date Title
TNSN98019A1 (en) ARYLSULFONYLAMINOHYDROXAMIC ACID DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
TNSN99203A1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF MIGRAINE, AND METHOD FOR THEIR PREPARATION
TNSN98017A1 (en) SULFONYLUREA DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
TNSN00252A1 (en) PHARMACEUTICAL COMPOSITIONS GENERATING INCREASED CONCENTRATIONS OF DRUGS
TNSN98025A1 (en) ARYLSULFONYLHYDROXAMIC ACID DERIVATIVES, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM.
TNSN99053A1 (en) ACID HYDROXAMIDES (4-ARYLSULFONYLAMINO) -TETRAHYDRO- PYRANNE-4-CARBOXYLIQUES), PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM
TNSN99170A1 (en) NOVEL SUBSTITUTED TETRAHYDROQUINOLEIN DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
TNSN00071A1 (en) PHARMACEUTICAL COMPOSITION COMPRISING A CYP2D6 INHIBITOR AND A CYP2D6 CATALYZED METABOLISM DRUG
CA2330500A1 (en) Pharmaceutical compositions capable of being gelled
TNSN99162A1 (en) NEW ALCYNYL SUBSTITUTE QUINOLEIN-2-ONE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
TNSN01017A1 (en) COMPOSITIONS COMPRISING AN AZALIDE ANTIBIOTIC, AND METHODS FOR THEIR PREPARATION
TNSN98082A1 (en) SUBSTITUTED DERIVATIVES IN C - 4 OF 9 - DESOXO - 9a - aza - 9a HOMOERYTHROMYCIN A.
TNSN98022A1 (en) N-HYDROXY-β-SULFONYLPROPIONAMIDE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
TNSN99171A1 (en) 4-CARBOXYAMINO-2-SUBSTITUE-1,2,3,4-TETRAHYDROQUINOLEINES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
TNSN98150A1 (en) DERIVATIVES OF ARYLOXYARYLSULFONYLAMINOHYDROXAMIC ACIDS; PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
BE1002249A4 (en) PHARMACEUTICAL COMPOSITIONS.
TNSN99055A1 (en) NEW BICYCLIC HYDROXAMIC ACID DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
TNSN99126A1 (en) NOVEL PYRROLOPYRIMIDINES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
TNSN98238A1 (en) NEW MACROLIDES
TNSN99156A1 (en) NOVEL HYDROXYPIPECOLATE-HYDROXAMIC ACID DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
TNSN99073A1 (en) NOVEL PYRAZOLOPYRIMIDINONES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
TNSN01173A1 (en) PHARMACEUTICAL COMPOSITIONS COMPRISING AN NMDA RECEPTOR ANTAGONIST.
TNSN99110A1 (en) NON-PEPTIDE INHIBITORS OF VLA-4 DEPENDENT CELL ADHESION, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
TNSN98084A1 (en) DERIVATIVES OF SUBSTITUTED MACROLIDES IN POSITION C-4
TNSN99155A1 (en) 1-ARYL-3-ARYLMETHYL-1,8-NAPHTYRIDINE-4 (1H) -ONES NOVELS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM